175 related articles for article (PubMed ID: 7814895)
21. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.
Vlachoyiannopoulos PG; Petrovas C; Tektonidou M; Krilis S; Moutsopoulos HM
J Clin Immunol; 1998 Nov; 18(6):380-91. PubMed ID: 9857282
[TBL] [Abstract][Full Text] [Related]
23. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
[TBL] [Abstract][Full Text] [Related]
24. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
[TBL] [Abstract][Full Text] [Related]
26. Binding of beta 2 glycoprotein I to activated polystyrene and its recognition by human IgG autoantibodies.
Keil LB; Galazka M; el-Kadi HS; Erickson EN; DeBari VA
Biotechnol Appl Biochem; 1995 Dec; 22(3):305-13. PubMed ID: 8573291
[TBL] [Abstract][Full Text] [Related]
27. Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I.
Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
J Clin Pathol; 1993 Jul; 46(7):665-7. PubMed ID: 8157757
[TBL] [Abstract][Full Text] [Related]
28. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner.
Price BE; Rauch J; Shia MA; Walsh MT; Lieberthal W; Gilligan HM; O'Laughlin T; Koh JS; Levine JS
J Immunol; 1996 Sep; 157(5):2201-8. PubMed ID: 8757347
[TBL] [Abstract][Full Text] [Related]
29. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
30. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
31. [Autoantibodies and thrombosis].
Koike T
Hokkaido Igaku Zasshi; 1997 Sep; 72(5):485-90. PubMed ID: 9363465
[TBL] [Abstract][Full Text] [Related]
32. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants.
Arvieux J; Darnige L; Caron C; Reber G; Bensa JC; Colomb MG
Thromb Haemost; 1995 Oct; 74(4):1120-5. PubMed ID: 8560423
[TBL] [Abstract][Full Text] [Related]
33. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of anti-beta 2-glycoprotein I antibodies.
Amengual O; Atsumi T; Khamashta MA; Hughes GR
Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
[TBL] [Abstract][Full Text] [Related]
35. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies.
Galli M; Comfurius P; Barbui T; Zwaal RF; Bevers EM
Thromb Haemost; 1992 Sep; 68(3):297-300. PubMed ID: 1440495
[TBL] [Abstract][Full Text] [Related]
37. Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies.
Kouts S; Wang MX; Adelstein S; Krilis SA
J Immunol; 1995 Jul; 155(2):958-66. PubMed ID: 7608571
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
[TBL] [Abstract][Full Text] [Related]
39. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.
George J; Gilburd B; Hojnik M; Levy Y; Langevitz P; Matsuura E; Koike T; Shoenfeld Y
J Immunol; 1998 Apr; 160(8):3917-23. PubMed ID: 9558098
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]